{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:35:26Z","timestamp":1790789726106,"version":"4.1.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2019,3,10]],"date-time":"2019-03-10T00:00:00Z","timestamp":1552176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Peer Reviewed Cancer Research Program, Department of Defense","award":["CA140056"],"award-info":[{"award-number":["CA140056"]}]},{"name":"CURE Childhood Cancer Foundation, and the Aflac Cancer and Blood Disorders Center"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,10]]},"DOI":"10.1093\/neuonc\/noz053","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T15:14:59Z","timestamp":1551712499000},"page":"786-799","source":"Crossref","is-referenced-by-count":40,"title":["Inhibition of mutant PPM1D enhances DNA damage response and growth suppressive effects of ionizing radiation in diffuse intrinsic pontine glioma"],"prefix":"10.1093","volume":"21","author":[{"given":"Mwangala Precious","family":"Akamandisa","sequence":"first","affiliation":[{"name":"Cancer Biology Program, Graduate Division of Biological and Biomedical Sciences, Laney Graduate School, Emory University, Atlanta, Georgia"},{"name":"Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia"},{"name":"Aflac Cancer and Blood Disorders Center, Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Nie","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia"},{"name":"Aflac Cancer and Blood Disorders Center, Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Nahta","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Emory University, Atlanta, GA"},{"name":"Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia"},{"name":"Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Hambardzumyan","sequence":"additional","affiliation":[{"name":"Cancer Biology Program, Graduate Division of Biological and Biomedical Sciences, Laney Graduate School, Emory University, Atlanta, Georgia"},{"name":"Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia"},{"name":"Aflac Cancer and Blood Disorders Center, Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"},{"name":"Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Craig","family":"Castellino","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia"},{"name":"Aflac Cancer and Blood Disorders Center, Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"},{"name":"Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,3,10]]},"reference":[{"issue":"12","key":"2019061005403394500_CIT0001","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1177\/0883073815601495","article-title":"Diffuse intrinsic pontine glioma: time for cautious optimism","volume":"31","author":"Hennika","year":"2016","journal-title":"J Child Neurol."},{"key":"2019061005403394500_CIT0002","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fonc.2015.00237","article-title":"DIPG in children\u2014what can we learn from the past?","volume":"5","author":"Vanan","year":"2015","journal-title":"Front Oncol."},{"key":"2019061005403394500_CIT0003","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fonc.2012.00205","article-title":"Diffuse intrinsic pontine glioma: poised for progress","volume":"2","author":"Warren","year":"2012","journal-title":"Front Oncol."},{"issue":"5","key":"2019061005403394500_CIT0004","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng.2936","article-title":"Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations","volume":"46","author":"Buczkowicz","year":"2014","journal-title":"Nat Genet."},{"key":"2019061005403394500_CIT0005","doi-asserted-by":"crossref","first-page":"11185","DOI":"10.1038\/ncomms11185","article-title":"Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma","volume":"7","author":"Nikbakht","year":"2016","journal-title":"Nat Commun."},{"issue":"5","key":"2019061005403394500_CIT0006","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ng.2925","article-title":"Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma","volume":"46","author":"Taylor","year":"2014","journal-title":"Nat Genet."},{"issue":"5","key":"2019061005403394500_CIT0007","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ng.2938","article-title":"The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma","volume":"46","author":"Wu","year":"2014","journal-title":"Nat Genet."},{"issue":"7","key":"2019061005403394500_CIT0008","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/ng.2995","article-title":"Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas","volume":"46","author":"Zhang","year":"2014","journal-title":"Nat Genet."},{"issue":"5","key":"2019061005403394500_CIT0009","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ccell.2017.09.014","article-title":"H3.3(K27M) cooperates with Trp53 loss and PDGFRA gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas","volume":"32","author":"Pathania","year":"2017","journal-title":"Cancer Cell."},{"issue":"1","key":"2019061005403394500_CIT0010","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ccell.2018.11.015","article-title":"Histone H3.3 K27M accelerates spontaneous brainstem glioma and drives restricted changes in bivalent gene expression","volume":"35","author":"Larson","year":"2019","journal-title":"Cancer Cell."},{"key":"2019061005403394500_CIT0011","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.biopha.2018.01.075","article-title":"NF-\u03baB-induced WIP1 expression promotes colorectal cancer cell proliferation through mTOR signaling","volume":"99","author":"Bai","year":"2018","journal-title":"Biomed Pharmacother."},{"issue":"9","key":"2019061005403394500_CIT0012","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/onc.2014.37","article-title":"The WIP1 oncogene promotes progression and invasion of aggressive medulloblastoma variants","volume":"34","author":"Buss","year":"2015","journal-title":"Oncogene."},{"issue":"3","key":"2019061005403394500_CIT0013","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11060-007-9470-8","article-title":"Medulloblastomas overexpress the p53-inactivating oncogene WIP1\/PPM1D","volume":"86","author":"Castellino","year":"2008","journal-title":"J Neurooncol."},{"issue":"3","key":"2019061005403394500_CIT0014","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1755-9294.2009.01047.x","article-title":"Significance of Wip1 overexpression in breast cancer: strong association with hormone receptor expression and nodal metastasis","volume":"2","author":"Choi","year":"2009","journal-title":"Basic Appl Pathol."},{"issue":"2","key":"2019061005403394500_CIT0015","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3892\/mmr.2016.6032","article-title":"Clinical significance of Wip1 overexpression and its association with the p38MAPK\/p53\/p16 pathway in NSCLC","volume":"15","author":"Yang","year":"2017","journal-title":"Mol Med Rep."},{"key":"2019061005403394500_CIT0016","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.2741\/3999","article-title":"Regulation of the Wip1 phosphatase and its effects on the stress response","volume":"17","author":"Lowe","year":"2012","journal-title":"Front Biosci (Landmark Ed)."},{"issue":"2","key":"2019061005403394500_CIT0017","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10555-008-9127-x","article-title":"The type 2C phosphatase Wip1: an oncogenic regulator of tumor suppressor and DNA damage response pathways","volume":"27","author":"Lu","year":"2008","journal-title":"Cancer Metastasis Rev."},{"issue":"7432","key":"2019061005403394500_CIT0018","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nature11725","article-title":"Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer","volume":"493","author":"Ruark","year":"2013","journal-title":"Nature."},{"issue":"4","key":"2019061005403394500_CIT0019","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1083\/jcb.201210031","article-title":"Gain-of-function mutations of PPM1D\/Wip1 impair the p53-dependent G1 checkpoint","volume":"201","author":"Kleiblova","year":"2013","journal-title":"J Cell Biol."},{"issue":"9","key":"2019061005403394500_CIT0020","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11910-014-0474-4","article-title":"The molecular landscape of pediatric brain tumors in the next-generation sequencing era","volume":"14","author":"Firme","year":"2014","journal-title":"Curr Neurol Neurosci Rep."},{"issue":"11","key":"2019061005403394500_CIT0021","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1182\/blood-2018-05-850339","article-title":"PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells","volume":"132","author":"Kahn","year":"2018","journal-title":"Blood."},{"issue":"42","key":"2019061005403394500_CIT0022","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1038\/onc.2016.96","article-title":"WIP1 modulates responsiveness to Sonic Hedgehog signaling in neuronal precursor cells and medulloblastoma","volume":"35","author":"Wen","year":"2016","journal-title":"Oncogene."},{"issue":"17","key":"2019061005403394500_CIT0023","doi-asserted-by":"crossref","first-page":"12935","DOI":"10.1074\/jbc.M109.071696","article-title":"Wild-type p53-induced phosphatase 1 dephosphorylates histone variant gamma-H2AX and suppresses DNA double strand break repair","volume":"285","author":"Moon","year":"2010","journal-title":"J Biol Chem."},{"issue":"4","key":"2019061005403394500_CIT0024","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/neuonc\/nos001","article-title":"HDM2 promotes WIP1-mediated medulloblastoma growth","volume":"14","author":"Buss","year":"2012","journal-title":"Neuro Oncol."},{"issue":"16","key":"2019061005403394500_CIT0025","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.4161\/cc.25694","article-title":"Genetic variants and mutations of PPM1D control the response to DNA damage","volume":"12","author":"Dudgeon","year":"2013","journal-title":"Cell Cycle."},{"issue":"3","key":"2019061005403394500_CIT0026","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1158\/1535-7163.MCT-15-0651","article-title":"Chemical inhibition of wild-type p53-induced phosphatase 1 (WIP1\/PPM1D) by GSK2830371 potentiates the sensitivity to MDM2 inhibitors in a p53-dependent manner","volume":"15","author":"Esfandiari","year":"2016","journal-title":"Mol Cancer Ther."},{"issue":"3","key":"2019061005403394500_CIT0027","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nchembio.1427","article-title":"Allosteric Wip1 phosphatase inhibition through flap-subdomain interaction","volume":"10","author":"Gilmartin","year":"2014","journal-title":"Nat Chem Biol."},{"issue":"8","key":"2019061005403394500_CIT0028","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/sj.onc.1210729","article-title":"A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D","volume":"27","author":"Rayter","year":"2008","journal-title":"Oncogene."},{"issue":"2","key":"2019061005403394500_CIT0029","doi-asserted-by":"crossref","first-page":"e0115635","DOI":"10.1371\/journal.pone.0115635","article-title":"WIP1 phosphatase as a potential therapeutic target in neuroblastoma","volume":"10","author":"Richter","year":"2015","journal-title":"PLoS One."},{"issue":"45","key":"2019061005403394500_CIT0030","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth","volume":"27","author":"Whiteside","year":"2008","journal-title":"Oncogene."},{"issue":"5","key":"2019061005403394500_CIT0031","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7150\/jca.17648","article-title":"Role of tumor microenvironment in tumorigenesis","volume":"8","author":"Wang","year":"2017","journal-title":"J Cancer."},{"issue":"1","key":"2019061005403394500_CIT0032","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nn.4185","article-title":"The role of microglia and macrophages in glioma maintenance and progression","volume":"19","author":"Hambardzumyan","year":"2016","journal-title":"Nat Neurosci."},{"issue":"11","key":"2019061005403394500_CIT0033","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1073\/pnas.1101657108","article-title":"Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma","volume":"108","author":"Monje","year":"2011","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"11","key":"2019061005403394500_CIT0034","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/cdd.2011.45","article-title":"Abrogation of Wip1 expression by RITA-activated p53 potentiates apoptosis induction via activation of ATM and inhibition of HdmX","volume":"18","author":"Spinnler","year":"2011","journal-title":"Cell Death Differ."},{"issue":"6386","key":"2019061005403394500_CIT0035","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1126\/science.aao4750","article-title":"Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq","volume":"360","author":"Filbin","year":"2018","journal-title":"Science."},{"issue":"12","key":"2019061005403394500_CIT0036","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/nm1146","article-title":"Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors","volume":"10","author":"Issaeva","year":"2004","journal-title":"Nat Med."},{"issue":"18","key":"2019061005403394500_CIT0037","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.1158\/1078-0432.CCR-12-2211","article-title":"Dual targeting of wild-type and mutant p53 by small molecule RITA results in the inhibition of N-Myc and key survival oncogenes and kills neuroblastoma cells in vivo and in vitro","volume":"19","author":"Burmakin","year":"2013","journal-title":"Clin Cancer Res."},{"issue":"4","key":"2019061005403394500_CIT0038","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1158\/1078-0432.CCR-09-1865","article-title":"High frequency of p53\/MDM2\/p14ARF pathway abnormalities in relapsed neuroblastoma","volume":"16","author":"Carr-Wilkinson","year":"2010","journal-title":"Clin Cancer Res."},{"key":"2019061005403394500_CIT0039","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejca.2016.12.007","article-title":"Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: a matched-cohort analysis on behalf of the SIOP-E-HGG\/DIPG working group","volume":"73","author":"Janssens","year":"2017","journal-title":"Eur J Cancer."}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noz053\/28535545\/noz053.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/21\/6\/786\/28788919\/noz053.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T05:41:00Z","timestamp":1560145260000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/21\/6\/786\/5372846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,10]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,3,10]]},"published-print":{"date-parts":[[2019,6,10]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noz053","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6]]},"published":{"date-parts":[[2019,3,10]]}}}